Dana Accelerator

Dana Accelerator is dedicated to expediting the availability of solutions for rare disease patients by fostering research and development in this critical area. As a subsidiary of HITCO Holding, Dana Accelerator is committed to driving innovation and progress in pharmaceutical manufacturing.

Dana Accelerator achieves its mission through the collaboration of talented young experts, seasoned professors, and trainers, all operating under the guidance of the Food and Drug Organization. This synergy ensures the highest standards of scientific rigor and regulatory compliance.

With the financial backing and investment of the Health Investment Tamin Company (HITCO), Dana Accelerator is well-positioned to accelerate advancements in rare disease treatments. We invite the management of Dana Accelerator to enhance your company's visibility and showcase your offerings through a customized and exclusive company showcase and product listing on our platform.